Cargando…
Letter to Editor-response: placebo response rates
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958350/ https://www.ncbi.nlm.nih.gov/pubmed/36851987 http://dx.doi.org/10.1016/j.eclinm.2023.101852 |
_version_ | 1784895004098953216 |
---|---|
author | Gyawali, Bishal |
author_facet | Gyawali, Bishal |
author_sort | Gyawali, Bishal |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9958350 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-99583502023-02-26 Letter to Editor-response: placebo response rates Gyawali, Bishal eClinicalMedicine Correspondence Elsevier 2023-02-14 /pmc/articles/PMC9958350/ /pubmed/36851987 http://dx.doi.org/10.1016/j.eclinm.2023.101852 Text en © 2023 The Author https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Correspondence Gyawali, Bishal Letter to Editor-response: placebo response rates |
title | Letter to Editor-response: placebo response rates |
title_full | Letter to Editor-response: placebo response rates |
title_fullStr | Letter to Editor-response: placebo response rates |
title_full_unstemmed | Letter to Editor-response: placebo response rates |
title_short | Letter to Editor-response: placebo response rates |
title_sort | letter to editor-response: placebo response rates |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958350/ https://www.ncbi.nlm.nih.gov/pubmed/36851987 http://dx.doi.org/10.1016/j.eclinm.2023.101852 |
work_keys_str_mv | AT gyawalibishal lettertoeditorresponseplaceboresponserates |